CE18 - Innovation biomédicale

“Green” bio-mimetic platform based on lipid nanoemulsions for detection of endothelial senescence – SenEmul

Submission summary

Atherothrombosis, a major cause of cardiovascular diseases including myocardial infarction, is a process that starts early in childhood and is accelerated by cardiovascular risk factors. The atherogenesis process is targeting initially well-defined arterial sites at risk such as bifurcations, characterized by a sub-optimal vascular protection, exposure to low shear forces and premature endothelial senescence. We will develop bio-inspired lipid nano-droplets (nanoemulsions) loaded with dyes and fluorinated agents for specific targeting and imaging of senescent endothelial cells. Fluorescence modality of nanoemulsions will be applied for in vitro and ex vivo studies in cultured and native healthy and senescent endothelial cells, whereas fluorine-19 MRI modality will allow detecting senescent cells in live animals. The developed “green” nanomaterials composed of non-toxic organic components will provide effective tools for diagnostics and prevention of the development of atherogenesis.

Project coordination


The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.


ICube Laboratoire des sciences de l'Ingénieur, de l'Informatique et de l'Imagerie
LBP Laboratoire de Bioimagerie et Pathologies (UMR 7021)

Help of the ANR 507,533 euros
Beginning and duration of the scientific project: September 2022 - 42 Months

Useful links

Explorez notre base de projets financés



ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter